Designing potential HIV-1 integrase inhibitors: An In silico approach

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Turkish Journal of Analytical Chemistry
Volume:3 Issue:2
Designing potential HIV-1 integrase inhibitors: An In silico approach

Designing potential HIV-1 integrase inhibitors: An In silico approach

Pages : 45-53

View : 38 | Download : 9

Publication Date : 2021-12-30

Article Type : Research Paper

Abstract :Human immunodeficiency virus is a spectrum of conditions caused by infection with the human immunodeficiency virus. In 2019, about 38 million people worldwide were living with HIV and 690,000 deaths had occurred in that year. To date, for the treatment of HIV-1 disease, many compounds have been synthesized and some of them was approved by FDA. However, the use of these drugs has been limited due to reasons such as resistance caused by the misuse of drugs and bad side effects. We describe herein designing 48 novel compounds as a potential inhibitor of HIV-1 integrase through in silico studies such as molecular docking, target analysis, toxicity prediction and ADME prediction. The online web-based platform, SwissADME, also predicts these molecules solubility, pharmacodynamics property and target accuracy.
Keywords : Swissadme, HIV 1 Integrase, Molecular Docking, In Silico Study, Toxicity

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.